Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy-Reference-Cited by-同舟云学术

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy

Published:1992-01-15 Issue:2 Volume:69 Page:448-452
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Buzdar Aman U.,Kau Shu-Wan,Hortobagyi Gabriel N.,Ames Frederick C.,Holmes Frankie A.,Fraschini Giuseppe,Hug Verena,Theriault Richard L.,McNeese Marsha D.,Singletary S. Eva

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference13 articles.

1. Management and survival of female breast cancer: Results of a national survey by the American college of surgeons

2. Development and Use of a Natural History Data Base of Breast Cancer Studies

3. Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure

4. , et al. Adjuvant chemotherapy trials in resectable breast cancer with positive axillary nodes: The experience of the Milan Cancer Institute. In: , eds. Adjuvant Therapy of Cancer IV. New York: Grune & Stratton, 1984; 195–207

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular subtypes are prognostic for N3 breast cancer patients in the modern therapeutic era;Molecular and Clinical Oncology;2018-11-19

2. Metastatic axillary node ratio predicts recurrence and poor long-term prognosis in patients with advanced stage IIIC (pN3) breast cancer;Annals of Surgical Treatment and Research;2017

3. Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes;Journal of Breast Cancer;2016

4. Long-Term Survival of Women with Locally Advanced Breast Cancer with ≥10 Involved Lymph Nodes at Diagnosis;Asian Pacific Journal of Cancer Prevention;2014-04-30

5. Outcomes of locally advanced breast cancer patients with ≥10 positive axillary lymph nodes;Medical Oncology;2013-06-01